 
  
  
  
  
      Find Clinical Trials
        
    Assessment of the acceptability of a sublingual formulation of piribedil (S90049), 10 to 30 mg on request (maximum 5 times a day) on the top of L-dopa and a dopamine agonist in advanced Parkinson Disease patients with motor fluctuations: a 4-week open label pilot study
                
                            
  
      Servier Protocol Code:
  
      
    SC3-90049-001
  
        
        
                            
  
      Sponsor:
  
      
    Institut de Recherches Internationales Servier (I.R.I.S)
  
        
        
        
        
                  
  
      EudraCT Number:
  
      
    
  
  2005-002010-38
  
              
    Find a recruiting site
            Name:
            Institut de Recherches Internationales Servier, Département des études cliniques
          
        
        
                  
            Phone number:
            +33 1 55 72 60 00
          
        
        
                  
              
        Results
      
      
      Interventions / Treatments
The treatment(s) given to the participants in the study.
  
- Parkinson's disease
- PIRIBEDIL
- S090049
Other study id numbers
Other identification numbers the study may be known by.
  
- SC3-90049-001